MDXHealth
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
07 nov 2008 - 10:08
Statutaire naam
MDXHealth
Titel
LabCorp presents positive results on GST-Pi/APC methylation test for detection of prostate cancer
Bericht
Liege (Belgium) – November 4 2008, 08:00 CET - OncoMethylome Sciences (Euronext Brussels: ONCOB, Euronext Amsterdam: ONCOA) announced today that Laboratory Corporation of America® Holdings (LabCorp®) presented results of LabCorp’s GST-Pi/APC methylation assay for the detection of prostate cancer at the Annual Meeting for Molecular Markers in Cancer sponsored by the American Society of Clinical Oncology (ASCO), the National Cancer Institute (NCI) and the European Organization for Research and Treatment of Cancer (EORTC). OncoMethylome licensed the prostate cancer applications to Veridex LLC, a Johnson & Johnson company, who subsequently issued a sublicense to LabCorp.
Gerelateerde downloads
Datum laatste update: 21 december 2025